Completed Genetics & Molecular Biology Cancer

Dynamical modelling of somatic genomes

In plain English

AI plain-English summary

Every cell in a tumour has a unique, chaotic genome, and this genetic chaos makes cancers more aggressive and harder to treat. Researchers are building simple mathematical models to track how this chaos—called chromosomal instability (CIN)—evolves over time in populations of cancer cells. The core problem is that we do not yet understand the normal evolutionary rules that govern CIN: how cells gain or lose whole chromosomes, restructure their DNA, or double their entire genome. Without that baseline, it is impossible to tell which genetic changes actually drive a cancer’s behaviour and which are merely noise. The team will fit their models to existing DNA sequencing data from both healthy and cancerous tissues, using Bayesian inference to infer the hidden evolutionary dynamics. This is fundamental science—it will not directly change a patient’s treatment tomorrow. But understanding how CIN evolves is a prerequisite for designing therapies that exploit its weaknesses. Similar work on the evolutionary dynamics of bacterial populations, for example, eventually led to smarter antibiotic dosing strategies. A clearer picture of how cancer genomes churn and select could, in time, reveal new targets for drugs or help predict which tumours will become drug-resistant before they do.

View original technical description
Cancers are complex and chaotic systems. It is becoming apparent that no two cells in a cancer are genetically identical or follow the same evolutionary trajectory. Chromosomal instability (CIN) is one way that cells generate this complexity and is a hallmark of all cancer and ageing. In cancer, it increases the level of variation available to cells and gives rise to intra-tumour genetic hetereogeneity, which makes the disease more agressive, drug tolerant, and harder to treat. We are still far from a complete understanding of how cells undergoing CIN evolve over time, in particular, we do not know how populations of cancer cells evolve and how selection acts to change these properties. Understanding this normal evolutionary behaviour will be key to separating the functional and non-functional aspects of intra-tumour heterogeneity. We will tackle this problem by understanding cancer as an emergent complex system, and use simple dynamic stochastic models to capture the essential biological features of the processes underlying CIN, including chromosome gain and loss, structural change, and genome doubling. We will use the vast amount of NGS data already available to fit these models using Bayesian inference and infer the evolutionary aspects of CIN in healthy and cancerous tissues.

View the original record at the funder ↗

Researchers

Chris BARNES (EPMC Awardee)

Related Research

Grants with similar aims, by meaning.

Predicting Routes Of Tumour Evolution driven by Unstable genomes and Selection
Stochastic modelling of cancer evolution
Data-driven probabilistic modelling of clonal dynamics in hu man tissues and cancers
Defining the origins and vulnerabilities of cancer chromosomal instability
Modelling of tissue level carcinogenesis through hybrid, biophysical, and executable approaches

Original classification

Senior Research Fellowship Basic

Plain English summaries and category classifications on this site are generated by AI and may not perfectly reflect the original research.